PGIM India Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.96%)Nav, as on 10-02-2025

  • Previous Nav

  • Net Change on 10-02-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI -3.39 -4.12 21.44 20.43 25.06 15.77

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 16.01 20.20 25.15 1.80 8,160.74
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 27.84 24.39 28.02 1.91 4,917.81
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 26.34 24.69 27.06 1.94 3,521.93
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 22.32 20.93 24.89 2.13 1,211.73
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 26.26 20.90 25.30 2.23 1,150.43

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Mankind Pharma Ltd.

  • Aster DM Healthcare Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Clearing Corporation of India Ltd.

  • Krishna Inst of Medical Sciences Ltd.

  • ICICI Lombard General Insurance Co. Ltd.

  • Cipla Ltd.

  • Abbott India Ltd.

  • Global Health Ltd.

  • Syngene International Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • Sagility India Ltd.

  • Ajanta Pharma Ltd.

  • IPCA Laboratories Ltd.

  • Dr. Lal Path Labs Ltd.

  • Navin Fluorine International Ltd.

  • PB Fintech Ltd.

  • Neuland Laboratories Ltd.

  • Zydus Lifesciences Ltd.

  • Sanofi Consumer Healthcare India Ltd.

  • Rainbow Children's Medicare Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Sanofi India Ltd.

  • Sai Life Sciences Ltd

  • Orchid Pharma Ltd.

  • Net Receivables / (Payables)

  • Akums Drugs And Pharmaceuticals Ltd.

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Miscellaneous

  • Insurance

  • Chemicals

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

View More

About PGIM India Healthcare Fund

Scheme Analysis

PGIM India Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to PGIM India Mutual Fund. It was launched on 06-Dec-2024 and currently has an AUM of ₹107.56 crore. PGIM India Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index.

The NAV of PGIM India Healthcare Fund ended down ₹-0.19(-1.96%)yesterday to ₹9.52.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The PGIM India Healthcare Fund is managed by Puneet Pal and Anandha Padmanabhan Anjeneyan.

Fund House Contact

4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 61593000
care@pgimindia.com
+91 (22) 61593100